SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001214659-16-011124
Filing Date
2016-04-29
Accepted
2016-04-29 17:15:18
Documents
5
Period of Report
2016-04-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 p4281618k.htm 8-K 50131
2 EXHIBIT 5.1 ex5_1.htm EX-5.1 10557
3 EXHIBIT 10.1 ex10_1.htm EX-10.1 22146
4 EXHIBIT 99.1 ex99_1.htm EX-99.1 8974
5 gplogo.jpg GRAPHIC 7571
  Complete submission text file 0001214659-16-011124.txt   103702
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34637 | Film No.: 161608254
SIC: 2834 Pharmaceutical Preparations